# OTO-104 for Meniere's Disease

> **NCT01084525** · PHASE1 · COMPLETED · sponsor: **Otonomy, Inc.** · enrollment: 44 (actual)

## Conditions studied

- Meniere's Disease

## Interventions

- **DRUG:** OTO-104 (steroid) 3 mg
- **DRUG:** Placebo
- **DRUG:** OTO-104 (steroid) 12 mg

## Key facts

- **NCT ID:** NCT01084525
- **Lead sponsor:** Otonomy, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-04
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084525, "OTO-104 for Meniere's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01084525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*